3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
38
Phase 2
36
Phase 1
27
Phase 3
26
Phase 1/2
16
Phase EARLY_PHASE1
2
Phase 4
1
Status
Withdrawn
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
CNS
1
Conditions
Recurrence
1
Neoplasms
1
Neoplasm Metastasis
1
Glioblastoma
1
Interventions
Saline Solution
6
Dexmedetomidine
5
Sodium Chloride
4
Temozolomide
3
Sevoflurane
3
Propofol
3
Methotrexate
3
Levetiracetam
3
trametinib
2
perampanel
2
dabrafenib
2
Sugammadex
2
Neuroimaging
2
Methylphenidate
2
Magnetic Resonance Spectroscopy
2
Granulocyte-Macrophage Colony-Stimulating Factor
2
Gentamicins
2
Fluorescein
2
Anesthesia, Inhalation
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
pembrolizumab
1
pegvisomant
1
olutasidenib
1
naxitamab
1
lorlatinib
1
gadoterate meglumine
1
gadobenic acid
1
durvalumab
1
dexketoprofen trometamol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Radiosurgery
×
CNS
×
Clear all
NCT05900908
2025-04-10
PATHWAyS
GT Medical Technologies, Inc.
Phase 4
Withdrawn